
Growth Hormone Deficiency Market
Description
The global Growth Hormone Deficiency market was valued at $3.13 billion in 2020 and is projected to reach $5.80 billion by 2028, growing at a CAGR of 7.99% from 2021 to 2028. This growth is driven by various macro and microeconomic factors, including a rise in cases of endocrine diseases, which serve as a primary driving factor for the market.
The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.
Segments covered
By Brands (Genotropin, Norditropin, Humatrope, Saizen, Omnitrope, Others)
By Route of Administration (Subcutaneous, Intramuscular, Intravenous, Oral, Others)
By Application (Growth Hormone Deficiency, Idiopathic Short Stature, Small for Gestational Age, Turner Syndrome, Prader-Willi Syndrome, Others)
By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Clinics, E-Commerce Websites, Others, )
Key players
Novo Nordisk A/S
Pfizer Inc
Novartis AG
Anhui Anke Biotechnology (Group) Co., Ltd
Biopartners GmbH
Ipsen S.A.
Eli Lily And Company
Merck KGaA
GeneScience Pharmaceuticals Co., Ltd
Lifetech Labs
The latest research report by Evolve Business Intelligence explores the various factors influencing the global market. It includes an analysis of the current market size, forecasts for key segments and regions, and the driving forces behind market growth. The report examines the potential impacts of key trends on business strategies and provides a SWOT analysis of critical sectors for each major competitor and customer group. This valuable data highlights the conglomerates likely to impact the industry, crucial for any company planning to invest strategically over the next five years. These insights complement our initial quantitative study, aiding in new investments and strategic planning to mitigate threats in existing sectors.
Segments covered
By Brands (Genotropin, Norditropin, Humatrope, Saizen, Omnitrope, Others)
By Route of Administration (Subcutaneous, Intramuscular, Intravenous, Oral, Others)
By Application (Growth Hormone Deficiency, Idiopathic Short Stature, Small for Gestational Age, Turner Syndrome, Prader-Willi Syndrome, Others)
By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Clinics, E-Commerce Websites, Others, )
Key players
Novo Nordisk A/S
Pfizer Inc
Novartis AG
Anhui Anke Biotechnology (Group) Co., Ltd
Biopartners GmbH
Ipsen S.A.
Eli Lily And Company
Merck KGaA
GeneScience Pharmaceuticals Co., Ltd
Lifetech Labs
Table of Contents
- Chapter 1. Executive Summary
- Chapter 2. Scope of The Study
- 2.1. Market Definition
- 2.2. Scope of The Study
- 2.2.1. Objectives of Report
- Chapter 3. Evolve BI Methodology
- Chapter 4. Market Insights and Trends
- 4.1. Supply/ Value Chain Analysis
- 4.2. Porter’s Five Forces Analysis
- 4.2.1. Threat of New Entrants
- 4.2.2. Bargaining Power of Buyers
- 4.2.3. Bargaining Power of Suppliers
- 4.2.4. Threat of Substitutes
- 4.2.5. Industry Rivalry
- 4.3. Impact of COVID-19 on Growth Hormone Deficiency Market
- 4.3.1. Impact on Market Size
- 4.3.2. Distribution Channel Trend, Preferences and Budget Impact
- 4.3.3. Regulatory Framework/Government Policies
- 4.3.4. Key Players Strategy to Tackle Negative Impact
- 4.3.5. Opportunity Window
- Chapter 5. Market Dynamics
- 5.1. Introduction
- 5.2. DRO Analysis
- 5.2.1. Drivers
- 5.2.2. Restraints
- 5.2.3. Opportunities
- Chapter 6. Global Growth Hormone Deficiency Market, By Brands
- 6.1. Introduction
- 6.2. Genotropin
- 6.3. Norditropin
- 6.4. Humatrope
- 6.5. Saizen
- 6.6. Omnitrope
- 6.7. Others
- Chapter 7. Global Growth Hormone Deficiency Market, By Route of Administration
- 7.1. Introduction
- 7.2. Subcutaneous
- 7.3. Intramuscular
- 7.4. Intravenous
- 7.5. Oral
- 7.6. Others
- Chapter 8. Global Growth Hormone Deficiency Market, By Application
- 8.1. Introduction
- 8.2. Growth Hormone Deficiency
- 8.3. Idiopathic Short Stature
- 8.4. Small for Gestational Age
- 8.5. Turner Syndrome
- 8.6. Prader-Willi Syndrome
- 8.7. Others
- Chapter 9. Global Growth Hormone Deficiency Market, By Distribution Channel
- 9.1. Introduction
- 9.2. Hospital Pharmacies
- 9.3. Retail Pharmacies
- 9.4. Clinics
- 9.5. E-Commerce Websites
- 9.6. Others
- Chapter 10. Global Growth Hormone Deficiency Market, By Region
- 10.1. Introduction
- 10.2. North America
- 10.2.1. Introduction
- 10.2.2. Driving Factors, Opportunity Analyzed and Key Trends
- 10.2.3. Market Size and Forecast, By Country, 2020 - 2028
- 10.2.4. Market Size and Forecast, By Brands, 2020 - 2028
- 10.2.5. Market Size and Forecast, By Route of Administration, 2020 - 2028
- 10.2.6. Market Size and Forecast, By Application, 2020 – 2028
- 10.2.7. Market Size and Forecast, By Distribution Channel, 2020 – 2028
- 10.2.8. US
- 10.2.8.1. Introduction
- 10.2.8.2. Driving Factors, Opportunity Analyzed and Key Trends
- 10.2.8.3. Market Size and Forecast, By Brands, 2020 - 2028
- 10.2.8.4. Market Size and Forecast, By Route of Administration, 2020 - 2028
- 10.2.8.5. Market Size and Forecast, By Application, 2020 – 2028
- 10.2.8.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 10.2.9. Canada
- 10.2.9.1. Introduction
- 10.2.9.2. Driving Factors, Opportunity Analyzed and Key Trends
- 10.2.9.3. Market Size and Forecast, By Brands, 2020 - 2028
- 10.2.9.4. Market Size and Forecast, By Route of Administration, 2020 - 2028
- 10.2.9.5. Market Size and Forecast, By Application, 2020 – 2028
- 10.2.9.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Driving Factors, Opportunity Analyzed and Key Trends
- 10.3.3. Market Size and Forecast, By Country, 2020 - 2028
- 10.3.4. Market Size and Forecast, By Brands, 2020 - 2028
- 10.3.5. Market Size and Forecast, By Route of Administration, 2020 - 2028
- 10.3.6. Market Size and Forecast, By Application, 2020 – 2028
- 10.3.7. Market Size and Forecast, By Distribution Channel, 2020 – 2028
- 10.3.8. Germany
- 10.3.8.1. Introduction
- 10.3.8.2. Driving Factors, Opportunity Analyzed and Key Trends
- 10.3.8.3. Market Size and Forecast, By Brands, 2020 - 2028
- 10.3.8.4. Market Size and Forecast, By Route of Administration, 2020 - 2028
- 10.3.8.5. Market Size and Forecast, By Application, 2020 – 2028
- 10.3.8.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 10.3.9. France
- 10.3.9.1. Introduction
- 10.3.9.2. Driving Factors, Opportunity Analyzed and Key Trends
- 10.3.9.3. Market Size and Forecast, By Brands, 2020 - 2028
- 10.3.9.4. Market Size and Forecast, By Route of Administration, 2020 - 2028
- 10.3.9.5. Market Size and Forecast, By Application, 2020 – 2028
- 10.3.9.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 10.3.10. UK
- 10.3.10.1. Introduction
- 10.3.10.2. Driving Factors, Opportunity Analyzed and Key Trends
- 10.3.10.3. Market Size and Forecast, By Brands, 2020 - 2028
- 10.3.10.4. Market Size and Forecast, By Route of Administration, 2020 - 2028
- 10.3.10.5. Market Size and Forecast, By Application, 2020 – 2028
- 10.3.10.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 10.3.11. Italy
- 10.3.11.1. Introduction
- 10.3.11.2. Driving Factors, Opportunity Analyzed and Key Trends
- 10.3.11.3. Market Size and Forecast, By Brands, 2020 - 2028
- 10.3.11.4. Market Size and Forecast, By Route of Administration, 2020 - 2028
- 10.3.11.5. Market Size and Forecast, By Application, 2020 – 2028
- 10.3.11.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 10.3.12. Rest of Europe
- 10.3.12.1. Introduction
- 10.3.12.2. Driving Factors, Opportunity Analyzed and Key Trends
- 10.3.12.3. Market Size and Forecast, By Brands, 2020 - 2028
- 10.3.12.4. Market Size and Forecast, By Route of Administration, 2020 - 2028
- 10.3.12.5. Market Size and Forecast, By Application, 2020 – 2028
- 10.3.12.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 10.4. Asia-Pacific
- 10.4.1. Introduction
- 10.4.2. Driving Factors, Opportunity Analyzed and Key Trends
- 10.4.3. Market Size and Forecast, By Country, 2020 - 2028
- 10.4.4. Market Size and Forecast, By Brands, 2020 - 2028
- 10.4.5. Market Size and Forecast, By Route of Administration, 2020 - 2028
- 10.4.6. Market Size and Forecast, By Application, 2020 – 2028
- 10.4.7. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 10.4.8. China
- 10.4.8.1. Introduction
- 10.4.8.2. Driving Factors, Opportunity Analyzed and Key Trends
- 10.4.8.3. Market Size and Forecast, By Brands, 2020 - 2028
- 10.4.8.4. Market Size and Forecast, By Route of Administration, 2020 - 2028
- 10.4.8.5. Market Size and Forecast, By Application, 2020 – 2028
- 10.4.8.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 10.4.9. India
- 10.4.9.1. Introduction
- 10.4.9.2. Driving Factors, Opportunity Analyzed and Key Trends
- 10.4.9.3. Market Size and Forecast, By Brands, 2020 - 2028
- 10.4.9.4. Market Size and Forecast, By Route of Administration, 2020 - 2028
- 10.4.9.5. Market Size and Forecast, By Application, 2020 – 2028
- 10.4.9.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 10.4.10. Japan
- 10.4.10.1. Introduction
- 10.4.10.2. Driving Factors, Opportunity Analyzed and Key Trends
- 10.4.10.3. Market Size and Forecast, By Brands, 2020 - 2028
- 10.4.10.4. Market Size and Forecast, By Route of Administration, 2020 - 2028
- 10.4.10.5. Market Size and Forecast, By Application, 2020 – 2028
- 10.4.10.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 10.4.11. South Korea
- 10.4.11.1. Introduction
- 10.4.11.2. Driving Factors, Opportunity Analyzed and Key Trends
- 10.4.11.3. Market Size and Forecast, By Brands, 2020 - 2028
- 10.4.11.4. Market Size and Forecast, By Route of Administration, 2020 - 2028
- 10.4.11.5. Market Size and Forecast, By Application, 2020 – 2028
- 10.4.11.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 10.4.12. Rest of Asia-Pacific
- 10.4.12.1. Introduction
- 10.4.12.2. Driving Factors, Opportunity Analyzed and Key Trends
- 10.4.12.3. Market Size and Forecast, By Brands, 2020 - 2028
- 10.4.12.4. Market Size and Forecast, By Route of Administration, 2020 - 2028
- 10.4.12.5. Market Size and Forecast, By Application, 2020 – 2028
- 10.4.12.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 10.5. Rest of The World (RoW)
- 10.5.1. Introduction
- 10.5.2. Driving Factors, Opportunity Analyzed and Key Trends
- 10.5.3. Market Size and Forecast, By Brands, 2020 - 2028
- 10.5.4. Market Size and Forecast, By Route of Administration, 2020 - 2028
- 10.5.5. Market Size and Forecast, By Application, 2020 – 2028
- 10.5.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 10.5.7. Market Size and Forecast, By Region, 2020 - 2028
- 10.5.8. South America
- 10.5.8.1. Introduction
- 10.5.8.2. Driving Factors, Opportunity Analyzed and Key Trends
- 10.5.8.3. Market Size and Forecast, By Brands, 2020 - 2028
- 10.5.8.4. Market Size and Forecast, By Route of Administration, 2020 - 2028
- 10.5.8.5. Market Size and Forecast, By Application, 2020 – 2028
- 10.5.8.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- 10.5.9. Middle East & Africa
- 10.5.9.1. Introduction
- 10.5.9.2. Driving Factors, Opportunity Analyzed and Key Trends
- 10.5.9.3. Market Size and Forecast, By Brands, 2020 - 2028
- 10.5.9.4. Market Size and Forecast, By Route of Administration, 2020 - 2028
- 10.5.9.5. Market Size and Forecast, By Application, 2020 – 2028
- 10.5.9.6. Market Size and Forecast, By Distribution Channel, 2020 - 2028
- Chapter 11. Competitive Landscape
- 11.1. Introduction
- 11.2. Vendor Share Analysis, 2020/Key Players Positioning, 2020
- Chapter 12. Company Profiles
- 12.1. Novo Nordisk A/S
- 12.1.1. Business Overview
- 12.1.2. Financial Analysis
- 12.1.3. Product Portfolio
- 12.1.4. Recent Development and Strategies Adopted
- 12.1.5. SWOT Analysis
- 12.2. Pfizer Inc
- 12.2.1. Business Overview
- 12.2.2. Financial Analysis
- 12.2.3. Product Portfolio
- 12.2.4. Recent Development and Strategies Adopted
- 12.2.5. SWOT Analysis
- 12.3. Novartis AG
- 12.3.1. Business Overview
- 12.3.2. Financial Analysis
- 12.3.3. Product Portfolio
- 12.3.4. Recent Development and Strategies Adopted
- 12.3.5. SWOT Analysis
- 12.4. Anhui Anke Biotechnology (Group) Co., Ltd
- 12.4.1. Business Overview
- 12.4.2. Financial Analysis
- 12.4.3. Product Portfolio
- 12.4.4. Recent Development and Strategies Adopted
- 12.4.5. SWOT Analysis
- 12.5. Biopartners GmbH
- 12.5.1. Business Overview
- 12.5.2. Financial Analysis
- 12.5.3. Product Portfolio
- 12.5.4. Recent Development and Strategies Adopted
- 12.5.5. SWOT Analysis
- 12.6. Ipsen S.A.
- 12.6.1. Business Overview
- 12.6.2. Financial Analysis
- 12.6.3. Product Portfolio
- 12.6.4. Recent Development and Strategies Adopted
- 12.6.5. SWOT Analysis
- 12.7. Eli Lily And Company
- 12.7.1. Business Overview
- 12.7.2. Financial Analysis
- 12.7.3. Product Portfolio
- 12.7.4. Recent Development and Strategies Adopted
- 12.7.5. SWOT Analysis
- 12.8. Merck KGaA
- 12.8.1. Business Overview
- 12.8.2. Financial Analysis
- 12.8.3. Product Portfolio
- 12.8.4. Recent Development and Strategies Adopted
- 12.8.5. SWOT Analysis
- 12.9. GeneScience Pharmaceuticals Co., Ltd
- 12.9.1. Business Overview
- 12.9.2. Financial Analysis
- 12.9.3. Product Portfolio
- 12.9.4. Recent Development and Strategies Adopted
- 12.9.5. SWOT Analysis
- 12.10. Lifetech Labs
- 12.10.1. Business Overview
- 12.10.2. Financial Analysis
- 12.10.3. Product Portfolio
- 12.10.4. Recent Development and Strategies Adopted
- 12.10.5. SWOT Analysis
- Chapter 13. Key Takeaways
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.